Supply Chain

Alnylam Pharmaceuticals will stop developing an experimental drug after a late-stage study showed patients given the treatment were more likely to die than those given a placebo, reports Reuters.

Wally Devereaux, the senior director of cargo and charters for Southwest Airlines, said the company plans to haul cargo on international flights in 2017, according to American Shipper.

DHL Supply Chain, a division of Bonn, Germany-based DHL Group, recently acquired MIT Safetrans, a transport and logistics company in Italy, reports The Stat Trade Times.

Here are the four latest drugs or medical devices approved by the Food and Drug Administration.

The Food and Drug Administration recently approved the Mi-eye 2, a second-generation device used to diagnose and treat joint injuries, reports Philadelphia Business Journal.

The Food and Drug Administration recently approved a new low dose version of Orexo's treatment for opioid dependence.

FedEx is building a new 240,000 square foot distribution center on a 32-acre plot of land in Miami Township, Ohio, reported ABC 22.

Insmed, a Bridgewater, N.J.-based drugmaker focusing on treatments for rare diseases, purchased the exclusive global rights to AstraZeneca's experimental respiratory drug AZD7986.

Novartis will close research operations in Switzerland and China, resulting in 175 job cuts, reports Reuters. The move represents an effort to lower costs and centralize control over the Basel, Switzerland-based company's drug development programs.

The House Oversight and Government Reform Committee is undeterred from its quest at uncovering exactly how much profit Canonsburg, Pa.-based Mylan makes on its EpiPen sales.